Elsevier

Neurochemistry International

Volume 27, Issues 4–5, October–November 1995, Pages 355-366
Neurochemistry International

Treatment with NMDA receptor antagonists does not affect developmental changes in NMDA receptor properties in vivo

https://doi.org/10.1016/0197-0186(95)00017-3Get rights and content

Abstract

Effects of acute and long-term treatment of neonatal rats with N-methyl-d-aspartate (NMDA) receptor antagonists on changes in NMDA receptor properties were examined. Animals received either on postnatal day 6 a single dose of the antagonists MK-801 (1 mg/kg), or D-CPPene (2 mg/kg) or during the period from postnatal day 5 to 14, two daily injections of MK-801 (0.25 mg/kg) or D-CPPene (0.75 mg/kg). Control littermates received saline injections. In both cases animals were sacrificed one day after the last injection. NMDA receptor properties were examined in membrane preparations derived from the cerebral cortex by studying the modulation of [3H]MK-801 binding by glutamate, Mg2+ and D-CPPene. The density of agonist- and antagonist-binding sites in the CAI region of the hippocampus were determined by autoradiography, using [3H]CGP39653 or [3H]glutamate as ligands. A significant developmental increase in NMDA receptor binding sites was detected both in preparations of cerebral cortical membranes and in the CAI area of the hippocampus. In addition, the Mg2+ sensitivity of [3H]MK-801 binding was significantly higher in membrane preparations from the cerebral cortex of postnatal day 15 compared to postnatal day 7 animals. Neither the single nor the subchronic treatment with NMDA receptor antagonists exerted a significant influence on the density of antagonist binding sites or on the modulation of [3H]MK-801 binding by glutamate, Mg2+ or D-CPPene. We conclude therefore that neonatal treatment with NMDA receptor antagonists in vivo does not involve significant alterations in the properties and the densities of NMDA receptors in the brain regions studied, i.e., during the period when expression of these receptors is subject to pronounced developmental regulation.

References (50)

  • R.E. Gibson et al.

    In vivo binding and autoradiographic imaging of (+)-3- [125I]Iodo-MK-801 to the NMDA receptor-channel complex in rat brain

    Nucl. Med. Biol.

    (1992)
  • B. Gordon et al.

    The effect of age on binding of MK-801 in the cat visual cortex

    Dev. Brain Res.

    (1991)
  • J.A. Gorter et al.

    Chronic neonatal MK-801 treatment results in an impairment of spatial learning in the adult rat

    Brain Res.

    (1992)
  • J.A. Gorter et al.

    Chronic neonatal NMDA receptor blockade with MK-801 alters monoamine metabolism in adult rat

    Neurosci. Lett.

    (1992)
  • J.A. Gorter et al.

    Hippocampal neuronal responsiveness to NMDA agonists and antagonists in the adult rat neonatally treated with MK-801

    Brain Res.

    (1992)
  • T.R. Insel et al.

    The ontogeny of excitatory amino acid receptors in rat forebrain—I. N-methyl-d-aspartate and quisqualate receptors

    Neuroscience

    (1990)
  • D. Jaarsma et al.

    Glutamate dehydrogenase improves binding of [3H]CGP39653 to NMDA receptor in the autoradiographic assay

    J. Neurosci. Meth.

    (1993)
  • J.W. McDonald et al.

    MK-801 protects the neonatal brain from hypoxicischemic damage

    Eur. J. Pharmac.

    (1987)
  • J.W. McDonald et al.

    Differential ontogenetic development of three receptors comprising the NMDA receptor/channel complex in the rat hippocampus

    Exp. Neurol.

    (1990)
  • J.W. McDonald et al.

    MK-801 pretreatment enhances N-methyl-d-aspartate mediated brain injury and increases brain N-methyl-d-aspartate recognition site binding in rats

    Neuroscience

    (1990)
  • J.W. McDonald et al.

    Physiological and pathophysiological roles of excitatory amino acids during central nervous system development

    Brain Res. Rev.

    (1990)
  • G.A. McPherson

    Analysis of radioligand binding experiments: a collection of computer programs for the IBM PC

    J. Pharmac. Meth.

    (1985)
  • G. Micheletti et al.

    Chronic administration of NMDA antagonists induces D2 receptor synthesis in rat striatum

    Mol. Brain Res.

    (1992)
  • A.M. Morin et al.

    [3H]MK-801 binding sites in neonate rat brain

    Brain Res.

    (1989)
  • R.A. Morrisett et al.

    Reduced sensitivity of the N-methyl-d-aspartate component of synaptic transmission to magnesium in hippocampal slices from immature rats

    Dev. Brain Res.

    (1990)
  • Cited by (7)

    • Early brain development disruption from NMDA receptor hypofunction: Relevance to schizophrenia

      2007, Brain Research Reviews
      Citation Excerpt :

      Facchinetti et al. (1993) found that chronic perinatal MK-801 treatment had no effect on NMDA receptor binding. Similarly, Van Lookeren Campagne et al. (1995) found that this treatment did not alter NMDA receptor binding properties in membrane preparations. Conversely, acute perinatal MK-801 administration increased expression of NMDA receptor subunits, especially NR2A, in the cortex, hippocampus and striatum (Wilson et al., 1998).

    • Modulation by magnesium of N-methyl-D-aspartate receptors in developing human brain

      1998, Archives of Disease in Childhood: Fetal and Neonatal Edition
    View all citing articles on Scopus

    Present address: F. Hoffmann-La Roche Ltd, PRPN, Bau 69/402, Grenzacherstrasse 124, CH-4002 Basel, Switzerland.

    Present address: University of California, Irvine, IRU in Brain Aging, Biosciences II, 2205 Irvine, CA 92717, U.S.A.

    View full text